Cash flow RaQualia Pharma Inc.

Stocks

4579

JP3967150008

Pharmaceuticals

Delayed Japan Exchange Other stock markets 06:23:29 11/06/2026 am IST			5-day change	1st Jan Change
440.00 ^JPY	-4.76%		-7.56%	-56.44%

13/02	RaQualia Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
13/02	Raqualia Pharma Inc. Provides Consolidated Earnings Guidance for Year Ending December 31, 2025	CI

f538bbc47.SEd_wVg0wLwR5zbpzoAWJbclYu_6Afg3s8xuXzSta8I.B3IUqAxCoe1GlUastNdzRNVTOonKdb9x_6k-EWLLXKoRIhD1alemj0S_Bg

Published financial data: RAQUALIA PHARMA INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	277.6Cr	291.8Cr	190.1Cr	310.7Cr	397.9Cr
Total Revenues	277.6Cr	291.8Cr	190.1Cr	310.7Cr	397.9Cr
Cost of Goods Sold, Total	32Cr	23Cr	24Cr	62Cr	71Cr
Gross Profit	245.5Cr	268.7Cr	165.6Cr	248.2Cr	326.7Cr
Selling General & Admin Expenses, Total	62Cr	57Cr	62Cr	78Cr	89Cr
R&D Expenses	112.7Cr	124.8Cr	137.2Cr	170.3Cr	159.9Cr
Depreciation & Amortization - (IS)	50L	60L	60L	70L	70L
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	20Cr	28Cr
Other Operating Expenses, Total	174.7Cr	182Cr	199.3Cr	269.5Cr	278.4Cr
Operating Income	71Cr	87Cr	-34Cr	-21Cr	48Cr
Interest Expense, Total	-10L	-60L	-70L	-4.2Cr	-5.9Cr
Interest And Investment Income	2.2Cr	1.3Cr	90L	80L	2.6Cr
Net Interest Expenses	2.1Cr	70L	20L	-3.4Cr	-3.3Cr
Currency Exchange Gains (Loss)	14Cr	4.3Cr	5.2Cr	3.8Cr	-4Cr
Other Non Operating Income (Expenses)	-10L	-1.7Cr	1.1Cr	-13Cr	10L
EBT, Excl. Unusual Items	87Cr	90Cr	-27Cr	-34Cr	41Cr
Gain (Loss) On Sale Of Investments	1.6Cr	-3.5Cr	-	40L	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-1Cr	30L	-2.2Cr	-2.3Cr	2.6Cr
Other Unusual Items	-	-1.8Cr	-	-	-
EBT, Incl. Unusual Items	88Cr	85Cr	-29Cr	-36Cr	44Cr
Income Tax Expense	12Cr	13Cr	2.9Cr	14Cr	16Cr
Earnings From Continuing Operations	76Cr	72Cr	-32Cr	-50Cr	27Cr
Net Income to Company	76Cr	72Cr	-32Cr	-50Cr	27Cr
Net Income - (IS)	76Cr	72Cr	-32Cr	-50Cr	27Cr
Net Income to Common Incl Extra Items	76Cr	72Cr	-32Cr	-50Cr	27Cr
Net Income to Common Excl. Extra Items	76Cr	72Cr	-32Cr	-50Cr	27Cr
Per Share Items
Net EPS - Basic	36.03	34.48	-14.95	-22.87	11.52
Basic EPS - Continuing Operations	36.03	34.48	-14.95	-22.87	11.52
Basic Weighted Average Shares Outstanding	2.1Cr	2.1Cr	2.16Cr	2.16Cr	2.37Cr
Net EPS - Diluted	36.03	34.47	-14.95	-22.87	11.36
Diluted EPS - Continuing Operations	36.03	34.47	-14.95	-22.87	11.36
Diluted Weighted Average Shares Outstanding	2.1Cr	2.1Cr	2.16Cr	2.16Cr	2.41Cr
Normalized Basic EPS	26.04	26.82	-7.87	-9.79	10.84
Normalized Diluted EPS	26.02	26.81	-7.87	-9.79	10.68
Supplemental Items
EBITDA	85Cr	101.4Cr	-16Cr	19Cr	97Cr
EBITA	71Cr	87Cr	-34Cr	-1Cr	77Cr
EBIT	71Cr	87Cr	-34Cr	-21Cr	48Cr
Effective Tax Rate - (Ratio)	14.11	14.94	-9.86	-38.27	37.53
Normalized Net Income	55Cr	56Cr	-17Cr	-21Cr	26Cr
Non-Cash Pension Expense	1Cr	1Cr	1.4Cr	1.5Cr	1.4Cr
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	6.3Cr	8.4Cr	8.2Cr
Research And Development Expense From Footnotes	112.7Cr	124.8Cr	137.2Cr	170.3Cr	159.9Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	234.5Cr	367.5Cr	371.4Cr	334Cr	324Cr
Short Term Investments	31Cr	25Cr	4.9Cr	10L	30L
Total Cash And Short Term Investments	265.8Cr	392.5Cr	376.3Cr	334.1Cr	324.3Cr
Accounts Receivable, Total	120.5Cr	60Cr	60Cr	69Cr	192.8Cr
Total Receivables	120.5Cr	60Cr	60Cr	69Cr	192.8Cr
Inventory	1Cr	80L	15Cr	17Cr	16Cr
Prepaid Expenses	9Cr	11Cr	19Cr	19Cr	16Cr
Other Current Assets, Total	4Cr	18Cr	26Cr	15Cr	19Cr
Total Current Assets	400.3Cr	482.2Cr	495.6Cr	453.8Cr	568.2Cr
Net Property Plant And Equipment	30Cr	39Cr	57Cr	53Cr	44Cr
Long-term Investments	90Cr	102Cr	130.6Cr	61Cr	60Cr
Goodwill	-	-	-	386.5Cr	370Cr
Other Intangibles, Total	3.3Cr	2.4Cr	3Cr	3.7Cr	3.2Cr
Deferred Tax Assets Long-Term	-	-	50L	7.8Cr	6.4Cr
Other Long-Term Assets, Total	20L	-	10L	10L	20L
Total Assets	523.4Cr	625.7Cr	687.1Cr	965.5Cr	1.05TCr
Liabilities
Accounts Payable, Total	4.5Cr	13Cr	5.4Cr	5.9Cr	7.3Cr
Accrued Expenses, Total	6.3Cr	6Cr	5.4Cr	6.9Cr	5.8Cr
Current Portion of Long-Term Debt	-	20L	1.2Cr	51Cr	51Cr
Current Portion of Leases	2.1Cr	4.2Cr	6.4Cr	6.9Cr	7.8Cr
Current Income Taxes Payable	23Cr	24Cr	18Cr	22Cr	32Cr
Other Current Liabilities	4.1Cr	2.4Cr	2.7Cr	26Cr	23Cr
Total Current Liabilities	40Cr	49Cr	39Cr	118.7Cr	127.5Cr
Long-Term Debt	-	90L	3.9Cr	265.1Cr	213.8Cr
Long-Term Leases	1.7Cr	17Cr	25Cr	22Cr	17Cr
Deferred Tax Liability Non Current	1.6Cr	20L	-	-	-
Other Non Current Liabilities	1.5Cr	8.9Cr	7.3Cr	2.8Cr	3.5Cr
Total Liabilities	45Cr	76Cr	75Cr	408.4Cr	361.9Cr
Common Stock, Total	225.6Cr	226.5Cr	266.7Cr	272Cr	324Cr
Additional Paid In Capital	244.6Cr	245.5Cr	285.7Cr	291Cr	343Cr
Retained Earnings	4.9Cr	77Cr	45Cr	-4.5Cr	23Cr
Comprehensive Income and Other	3.5Cr	40L	15Cr	-1.4Cr	-20L
Total Common Equity	478.6Cr	549.7Cr	611.9Cr	557.1Cr	689.5Cr
Total Equity	478.6Cr	549.7Cr	611.9Cr	557.1Cr	689.5Cr
Total Liabilities And Equity	523.4Cr	625.7Cr	687.1Cr	965.5Cr	1.05TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.1Cr	2.16Cr	2.16Cr	2.18Cr	2.6Cr
ECS Total Common Shares Outstanding	2.1Cr	2.1Cr	2.16Cr	2.18Cr	2.45Cr
Book Value / Share	228.43	262.05	282.98	255.1	281.91
Tangible Book Value	475.3Cr	547.3Cr	608.9Cr	166.9Cr	316.3Cr
Tangible Book Value Per Share	226.86	260.9	281.6	76.43	129.32
Total Debt	3.8Cr	22Cr	37Cr	345Cr	289.9Cr
Net Debt	-262Cr	-370.5Cr	-339.7Cr	11Cr	-34Cr
Inventories - Raw Materials, Total	1Cr	70L	15Cr	17Cr	16Cr
Inventories - Work In Process, Total	-	-	10L	10L	-
Inventories - Others	-	10L	-	-	-
Full Time Employees	67	65	67	85	85

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	88Cr	85Cr	-29Cr	-36Cr	44Cr
Depreciation & Amortization - CF	14Cr	15Cr	18Cr	20Cr	20Cr
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	20Cr	28Cr
Depreciation & Amortization, Total	14Cr	15Cr	18Cr	40Cr	49Cr
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-1.6Cr	3.5Cr	-	-30L	-
Other Operating Activities, Total	-8.1Cr	-20Cr	-13Cr	-10Cr	-13Cr
Change In Accounts Receivable	-67Cr	60Cr	-	-8.5Cr	-123.9Cr
Change In Inventories	-40L	20L	-14Cr	30L	70L
Change In Accounts Payable	14Cr	11Cr	-13Cr	-9.8Cr	7.6Cr
Change in Other Net Operating Assets	-1.6Cr	-6.6Cr	-20Cr	42Cr	90L
Cash from Operations	37Cr	148Cr	-72Cr	18Cr	-35Cr
Capital Expenditure	-9.2Cr	-3.1Cr	-20Cr	-9.6Cr	-6.7Cr
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-	-	-387.9Cr	-
Sale (Purchase) of Intangible assets	-1.3Cr	-	-1.7Cr	-1.9Cr	-70L
Investment in Marketable and Equity Securities, Total	-17Cr	-1.5Cr	9Cr	16Cr	20Cr
Other Investing Activities, Total	-	-10L	-30L	17Cr	-20L
Cash from Investing	-28Cr	-4.7Cr	-14Cr	-366.5Cr	12Cr
Short Term Debt Issued, Total	1Cr	-	-	40Cr	-
Long-Term Debt Issued, Total	-	1.3Cr	5Cr	335.7Cr	-
Total Debt Issued	1Cr	1.3Cr	5Cr	375.7Cr	-
Short Term Debt Repaid, Total	-1Cr	-	-	-40Cr	-
Long-Term Debt Repaid, Total	-	-20L	-1.1Cr	-39Cr	-51Cr
Total Debt Repaid	-1Cr	-20L	-1.1Cr	-79Cr	-51Cr
Issuance of Common Stock	10L	40L	80Cr	8Cr	101.9Cr
Other Financing Activities, Total	-1.7Cr	-4.4Cr	-5.1Cr	-6.8Cr	-13Cr
Cash from Financing	-1.6Cr	-2.9Cr	79Cr	298.2Cr	38Cr
Foreign Exchange Rate Adjustments	11Cr	3.5Cr	4.5Cr	-2Cr	-4.5Cr
Miscellaneous Cash Flow Adjustments	-10L	-10L	10L	10L	-10L
Net Change in Cash	18Cr	143.8Cr	-1.4Cr	-52Cr	10Cr
Supplemental Items
Cash Interest Paid	10L	60L	60L	4.2Cr	5.9Cr
Cash Income Tax Paid (Refund)	7.6Cr	18Cr	11Cr	10Cr	14Cr
Levered Free Cash Flow	6.49Cr	117.21Cr	-69Cr	42Cr	-48Cr
Unlevered Free Cash Flow	6.55Cr	117.59Cr	-69Cr	44Cr	-45Cr
Change In Net Working Capital	41Cr	-52Cr	43Cr	-29Cr	116.3Cr
Net Debt Issued / Repaid	0	1.1Cr	3.9Cr	297Cr	-51Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	9.33	9.43	-3.21	-1.61	2.99
Return on Total Capital	9.97	10.28	-3.45	-1.72	3.21
Return On Equity %	17.17	14.06	-5.56	-8.47	4.38
Return on Common Equity	17.17	14.06	-5.56	-8.47	4.38
Margin Analysis
Gross Profit Margin %	88.44	92.08	87.11	79.88	82.11
SG&A Margin	22.15	19.4	32.35	25.17	22.44
EBITDA Margin %	30.58	34.75	-8.52	6.05	24.38
EBITA Margin %	25.5	29.71	-17.73	-0.32	19.3
EBIT Margin %	25.5	29.71	-17.73	-6.86	12.14
Income From Continuing Operations Margin %	27.2	24.78	-16.99	-15.93	6.86
Net Income Margin %	27.2	24.78	-16.99	-15.93	6.86
Net Avail. For Common Margin %	27.2	24.78	-16.99	-15.93	6.86
Normalized Net Income Margin	19.66	19.28	-8.94	-6.82	6.46
Levered Free Cash Flow Margin	2.34	40.17	-36.51	13.38	-12.19
Unlevered Free Cash Flow Margin	2.36	40.3	-36.28	14.22	-11.26
Asset Turnover
Asset Turnover	0.59	0.51	0.29	0.38	0.39
Fixed Assets Turnover	8.8	8.46	3.94	5.64	8.25
Receivables Turnover (Average Receivables)	3.2	3.23	3.16	4.81	3.04
Inventory Turnover (Average Inventory)	40.12	25.67	3.16	3.98	4.37
Short Term Liquidity
Current Ratio	10.01	9.78	12.74	3.82	4.46
Quick Ratio	9.66	9.18	11.22	3.4	4.06
Operating Cash Flow to Current Liabilities	0.92	3	-1.85	0.15	-0.28
Days Sales Outstanding (Average Receivables)	114.06	113.01	115.68	76.1	120.03
Days Outstanding Inventory (Average Inventory)	9.1	14.22	115.46	91.94	83.56
Average Days Payable Outstanding	48.85	137.87	86.5	32.06	34.22
Cash Conversion Cycle (Average Days)	74.31	-10.64	144.64	135.98	169.37
Long Term Solvency
Total Debt/Equity	0.79	4	5.98	61.93	42.04
Total Debt / Total Capital	0.79	3.85	5.64	38.24	29.6
LT Debt/Equity	0.36	3.2	4.74	51.5	33.49
Long-Term Debt / Total Capital	0.35	3.08	4.47	31.8	23.58
Total Liabilities / Total Assets	8.56	12.15	10.94	42.3	34.42
EBIT / Interest Expense	708	144.5	-48.14	-5.07	8.19
EBITDA / Interest Expense	849	169	-23.14	4.48	16.44
(EBITDA - Capex) / Interest Expense	757	163.83	-52.43	2.19	15.31
Total Debt / EBITDA	0.04	0.22	-2.26	18.35	2.99
Net Debt / EBITDA	-3.09	-3.65	20.97	0.58	-0.35
Total Debt / (EBITDA - Capex)	0.05	0.22	-1	37.5	3.21
Net Debt / (EBITDA - Capex)	-3.46	-3.77	9.26	1.18	-0.38
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	150.77	5.12	-34.85	63.44	28.07
Gross Profit, 1 Yr. Growth %	153.35	9.45	-38.37	49.88	31.63
EBITDA, 1 Yr. Growth %	-334.53	19.43	-115.98	-216.05	415.96
EBITA, 1 Yr. Growth %	-245.68	22.46	-138.87	-97.03	-7.78T
EBIT, 1 Yr. Growth %	-245.68	22.46	-138.87	-36.8	-326.76
Earnings From Cont. Operations, 1 Yr. Growth %	-224.59	-4.24	-144.67	53.25	-155.15
Net Income, 1 Yr. Growth %	-224.59	-4.24	-144.67	53.25	-155.15
Normalized Net Income, 1 Yr. Growth %	-265.65	3.09	-130.22	24.63	-221.24
Diluted EPS Before Extra, 1 Yr. Growth %	-224.57	-4.34	-143.37	53	-149.67
Accounts Receivable, 1 Yr. Growth %	127.36	-50.04	0.17	14.26	179.83
Inventory, 1 Yr. Growth %	66.67	-20	1.74T	13.61	-4.79
Net Property, Plant and Equip., 1 Yr. Growth %	-9.94	30.77	46.55	-7.68	-17.58
Total Assets, 1 Yr. Growth %	23.12	19.55	9.81	40.52	8.9
Tangible Book Value, 1 Yr. Growth %	19.54	15.15	11.26	-72.59	89.51
Common Equity, 1 Yr. Growth %	19.38	14.86	11.32	-8.96	23.77
Cash From Operations, 1 Yr. Growth %	-226.64	304.37	-148.51	-125.07	-296.67
Capital Expenditures, 1 Yr. Growth %	-38.26	-66.3	561.29	-53.17	-30.21
Levered Free Cash Flow, 1 Yr. Growth %	-131.84	1.71T	-159.21	-159.89	-216.69
Unlevered Free Cash Flow, 1 Yr. Growth %	-132.15	1.7T	-158.65	-164.07	-201.41
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	27.71	62.36	-17.25	3.19	44.68
Gross Profit, 2 Yr. CAGR %	30.57	66.52	-17.87	-3.89	40.46
EBITDA, 2 Yr. CAGR %	161.66	67.36	-56.32	-56.94	144.7
EBITA, 2 Yr. CAGR %	565.21	33.56	-31.01	-89.26	50.96
EBIT, 2 Yr. CAGR %	565.21	33.56	-31.01	-50.43	19.72
Earnings From Cont. Operations, 2 Yr. CAGR %	1.13T	9.23	-34.59	-17.26	-8.07
Net Income, 2 Yr. CAGR %	1.13T	9.23	-34.59	-17.26	-8.07
Normalized Net Income, 2 Yr. CAGR %	616.61	30.68	-44.18	-38.63	22.92
Diluted EPS Before Extra, 2 Yr. CAGR %	1.12T	9.16	-35.59	-18.54	-12.83
Accounts Receivable, 2 Yr. CAGR %	27.01	6.58	-29.26	6.98	78.81
Inventory, 2 Yr. CAGR %	41.42	15.47	283.41	356.89	4
Net Property, Plant and Equip., 2 Yr. CAGR %	9.8	8.52	38.43	16.32	-12.77
Total Assets, 2 Yr. CAGR %	4.03	21.32	14.58	24.22	23.7
Tangible Book Value, 2 Yr. CAGR %	1.79	17.32	13.18	-44.78	-27.93
Common Equity, 2 Yr. CAGR %	1.79	17.1	13.07	0.67	6.15
Cash From Operations, 2 Yr. CAGR %	-16.9	126.3	40.06	-65.13	-29.78
Capital Expenditures, 2 Yr. CAGR %	13.83	-54.39	49.27	75.98	-42.83
Levered Free Cash Flow, 2 Yr. CAGR %	-69.31	139.85	227.07	-40.45	-16.4
Unlevered Free Cash Flow, 2 Yr. CAGR %	-69.17	140.23	224.48	-38.7	-19.39
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	55.1	19.69	19.75	3.83	10.89
Gross Profit, 3 Yr. CAGR %	55.34	23.11	19.56	0.37	6.73
EBITDA, 3 Yr. CAGR %	-3.68	101.47	-23.51	-39.5	-1.47
EBITA, 3 Yr. CAGR %	-13	278.41	-11.49	-75.83	-3.96
EBIT, 3 Yr. CAGR %	-13	278.41	-11.49	-32.99	-17.72
Earnings From Cont. Operations, 3 Yr. CAGR %	-11.9	424.88	-18.92	-13.13	-27.72
Net Income, 3 Yr. CAGR %	-11.9	424.88	-18.92	-13.13	-27.72
Normalized Net Income, 3 Yr. CAGR %	-6.41	275.49	-19.79	-27.04	-22.99
Diluted EPS Before Extra, 3 Yr. CAGR %	-12.72	421.64	-19.75	-14.06	-30.93
Accounts Receivable, 3 Yr. CAGR %	-	-6.94	4.4	-17	47.4
Inventory, 3 Yr. CAGR %	18.56	16.96	190.44	155.61	170.88
Net Property, Plant and Equip., 3 Yr. CAGR %	-1.93	16.39	19.95	20.95	3.7
Total Assets, 3 Yr. CAGR %	8.91	8.97	17.36	22.64	18.89
Tangible Book Value, 3 Yr. CAGR %	7.52	6.06	15.27	-29.45	-16.7
Common Equity, 3 Yr. CAGR %	7.46	5.97	15.14	5.19	7.85
Cash From Operations, 3 Yr. CAGR %	-3.16	40.82	35.44	-21.07	-37.93
Capital Expenditures, 3 Yr. CAGR %	-24.53	-24.14	11.22	1.43	29.29
Levered Free Cash Flow, 3 Yr. CAGR %	-24.19	19.38	50.46	85.73	-25.48
Unlevered Free Cash Flow, 3 Yr. CAGR %	-23.94	19.5	50.14	88.95	-27.5
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	15.51	20.64	12.79	29.16
Gross Profit, 5 Yr. CAGR %	-	16.17	20.38	11.5	27.52
EBITDA, 5 Yr. CAGR %	-	73.23	-29.8	8.68	21.79
EBITA, 5 Yr. CAGR %	-	42.03	-20.71	-8.97	9.58
EBIT, 5 Yr. CAGR %	-	42.03	-20.71	67.82	-0.12
Earnings From Cont. Operations, 5 Yr. CAGR %	-	65.63	-21.79	150.68	-14.74
Net Income, 5 Yr. CAGR %	-	65.63	-21.79	150.68	-14.74
Normalized Net Income, 5 Yr. CAGR %	-	63.09	-23.89	81.95	-4.85
Diluted EPS Before Extra, 5 Yr. CAGR %	-	63.1	-22.71	148.2	-17.05
Accounts Receivable, 5 Yr. CAGR %	-	6.09	-	-1.6	29.47
Inventory, 5 Yr. CAGR %	-	9.86	89.6	101.72	92.6
Net Property, Plant and Equip., 5 Yr. CAGR %	-	12.71	12.57	16.36	5.6
Total Assets, 5 Yr. CAGR %	-	4.32	11.14	14.83	19.85
Tangible Book Value, 5 Yr. CAGR %	-	2.32	9.75	-18.31	-4.47
Common Equity, 5 Yr. CAGR %	-	2.38	9.67	3.82	11.46
Cash From Operations, 5 Yr. CAGR %	-	36.97	12.24	-19.43	4.14
Capital Expenditures, 5 Yr. CAGR %	-	-18.83	-0.86	6.22	-14.77
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	36.05	-9.62	18.94
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	35.88	-8.5	17.07